Star of the show: iTeos-GSK's TIGIT combo shows 30% more tumor shrinkage than Jemperli in ph. 2

Star of the show: iTeos-GSK's TIGIT combo shows 30% more tumor shrinkage than Jemperli in ph. 2 gmasson Fri, 09/13/2024 - 16:22